Stroke PRG Clinical Trials

NINDS-supported clinical trials: Pilot studies, Phase I, Phase II

New MRI Techniques Prior to T-PA Therapy after Stroke
Grant Number: 1R01NS39325-01A1
Principal Investigator: Albers, G

Secondary Prevention in Small Subcortical Strokes (SPS3)
Grant Number: 5R01NS38529-02
Principal Investigator: Benavente, O

Interventional Management of Stroke (IMS) Study
Grant Number: 1R01NS39160-01A1
Principal Investigator: Broderick, J

Amphetamine Enhanced Stroke Recovery -Burke SRCI Group
Grant Number: 1R01NS39934-01
Principal Investigator: Goldstein, L

Pilot Study of TNK-TPA in Acute Ischemic Stroke
Grant Number: 1R01NS37666-01A1
Principal Investigator: Haley, E

Angioplasty in Aneurysmal Subarachnoid Hemorrhage
Grant Number: 1R01NS38484-01A1
Principal Investigator: Muizelaar, J

Coronary Artery Bypass Endarterectomy Staging Trial
Grant Number: 1R01NS39336-01
Principal Investigator: Ricotta, J

Hemicraniectomy for Swelling from Cerebral Infarction
Grant Number: 5R01NS40229-02
Principal Investigator: Frank, J

EMG-Controlled Stimulation for Stroke Rehabilitation
Grant Number: 2R44NS36484-02
Principal Investigator: Fang, Z

NINDS-supported clinical trials: Phase III

Extracranial/Intracranial Arterial Anastomosis Study
Principal Investigator: Barnett, H
Grant Number: NS14164
Date Ended: 1984

Brain Resuscitation Clinical Trial I, II, III
Principal Investigator: Abramson, N
Grant Number: NS15295
Date Ended: 1993

Asymptomatic Carotid Artery Stenosis Collaborative Study
Principal Investigator: Toole, J
Grant Number: NS22611
Date Ended: 1996

Stroke Prevention In Atrial Fibrillation I, III, III
Principal Investigator: Hart, R
Grant Number: NS24224
Date Ended: 1997

North American Carotid Endarterectomy Trial
Principal Investigator: Barnett, H
Grant Number: NS24456
Date Ended: 1997

Randomized Trial Of Org-10172 In Acute Ischemic Stroke
Principal Investigator: Adams, H
Grant Number: NS27863
Date Ended: 1997

Warfarin Antiplatelet Recurrent Stroke Study
Principal Investigator: Mohr, J
Grant Number: NS28371
Date Ended: 2000

Womens Estrogen For Stroke Trial
Principal Investigator: Horwitz, R
Grant Number: NS31251
Date Ended: 2000

Randomized Trial of Tirilazad in Acute Stroke Patients
Principal Investigator: Haley, E
Grant Number: NS31554
Date Ended: 1994

Aspirin (ASA) And Carotid Endarterectomy
Principal Investigator: Taylor, D
Grant Number: NS32832
Date Ended: 1995

African American Antiplatelet Stroke Prevention Study
Principal Investigator: Gorelick, P
Grant Number: NS33430
Date Ended: Current

Vitamin Intervention For Stroke Prevention
Principal Investigator: Toole, J
Grant Number: NS34447
Date Ended: Current

Warfarin vs. Aspirin For Intracranial Arterial Stenosis
Principal Investigator: Chimowitz, M
Grant Number: NS36643
Date Ended: Current

Efficacy Of A Family Telephone Intervention For Stroke
Principal Investigator: Miller, I
Grant Number: NS37840
Date Ended: Current

Hypothermia During Intracranial Aneurysm Surgery
Principal Investigator: Todd, M
Grant Number: NS38554
Date Ended: Current

Theory-Based Interventions For Smoking And Obesity
Principal Investigator: Jeffery, R
Grant Number: NS38441
Date Ended: Current

Carotid Revascularization Endarterectomy vs. Stenting
Principal Investigator: Hobson, R
Grant Number: NS38384
Date Ended: Current

Randomized Trial Of Treatment For Post-Stroke Depression
Principal Investigator: Williams, L
Grant Number: NS39571
Date Ended: Current

Extremity Constraint Induced Therapy Evaluation (Excite)
Principal Investigator: Wolf, S
Grant Number: HD37606
Date Ended: Current

Carotid Occlusion Surgery Study
Principal Investigator: Powers, W
Grant Number: NS42167
Date Ended: Pending

Warfarin vs Aspirin in Reduced Ejection Fraction
Principal Investigator: Pullicino, P
Grant Number: NS39154
Date Ended: Pending

NIH-supported Stroke clinical trials

Use this form to search for all NIH clinical trials which contain the terms "Stroke" and "NIH". The resulting list will include "false positives" including all non-stroke grants sponsored by the National Institute of Neurological Disorders and STROKE as well as trials where STROKE is listed as part of the exclusion criteria.